Familial hypercholesterolemia - treatment update in children, systematic review
- PMID: 35848473
- PMCID: PMC10214937
- DOI: 10.5114/pedm.2022.116112
Familial hypercholesterolemia - treatment update in children, systematic review
Abstract
Familial hypercholesterolaemia is one of the most common genetic diseases, and its first symptoms occur in childhood. Proper diagnosis and treatment prevent young patients from severe consequences in their future. The treatment of this dyslipidaemia is still evolving, and new promising agents are being discovered. In this review we summarize the old and new treatment methods of familial hypercholesterolaemia, giving an update estimated on the latest publications.
Rodzinna hipercholesterolemia jest jedną z najczęstszych chorób o podłożu genetycznym, a jej pierwsze objawy pojawiają się już w dzieciństwie. Właściwie postawiona diagnoza i leczenie może uchronić młodych pacjentów przed poważnymi konsekwencjami zdrowotnymi w przyszłości. Sposoby leczenia tej dyslipidemii ewoluują i pojawiają się nowe obiecujące leki. W pracy podsumowano już znane oraz nowe metody leczenia rodzinnej hipercholesterolemii, dokonując przeglądu najnowszej literatury.
Keywords: adolescents; children; cholesterol.; hyperlipoproteinaemia; hypercholesterolaemia.
Conflict of interest statement
none declared.
Similar articles
-
Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia.Eur J Prev Cardiol. 2022 Jul 20;29(9):1361-1368. doi: 10.1093/eurjpc/zwac025. Eur J Prev Cardiol. 2022. PMID: 35175352 Clinical Trial.
-
Familial Hypercholesterolemia in Children and Adolescents: Diagnosis and Treatment.Curr Pharm Des. 2018;24(31):3672-3677. doi: 10.2174/1381612824666181010145807. Curr Pharm Des. 2018. PMID: 30317987 Review.
-
Statins for children with familial hypercholesterolemia.Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD006401. doi: 10.1002/14651858.CD006401.pub5. Cochrane Database Syst Rev. 2019. PMID: 31696945 Free PMC article.
-
Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoin.Hong Kong Med J. 2018 Aug;24(4):408-415. doi: 10.12809/hkmj187215. Hong Kong Med J. 2018. PMID: 30100583
-
[Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].Cas Lek Cesk. 1998 Feb 9;137(3):67-72. Cas Lek Cesk. 1998. PMID: 9511274 Review. Czech.
Cited by
-
Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis.Eur Heart J Open. 2025 Jan 13;5(1):oeaf001. doi: 10.1093/ehjopen/oeaf001. eCollection 2025 Jan. Eur Heart J Open. 2025. PMID: 39944782 Free PMC article.
-
When Being Overweight Masks the Diagnosis: Identifying Familial Hypercholesterolemia in Pediatric Patients.Cureus. 2025 Jun 12;17(6):e85836. doi: 10.7759/cureus.85836. eCollection 2025 Jun. Cureus. 2025. PMID: 40656419 Free PMC article.
-
Clinical Management of Dyslipidemia in Infants and Toddlers.Curr Atheroscler Rep. 2025 Jun 4;27(1):61. doi: 10.1007/s11883-025-01305-y. Curr Atheroscler Rep. 2025. PMID: 40465020 Free PMC article. Review.
-
Lipid disorders in children - an underestimated problem.Pediatr Endocrinol Diabetes Metab. 2022;28(4):241-244. doi: 10.5114/pedm.2022.122050. Pediatr Endocrinol Diabetes Metab. 2022. PMID: 36734389 Free PMC article. No abstract available.
References
-
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421. - PubMed
-
- De Ferranti SD, Newburge JW. Dyslipidemia in children and adolescents: Definition, screening, and diagnosis. UpToDate. https://www.uptodate.com/contents/dyslipidemia-in-children-and-adoles-ce... (Accessed 10.01.2022).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources